These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 27614350)

  • 61. Immunogenicity of fusion proteins. An example of tumor-specific/transformation-related antigens.
    Gambacorti-Passerini C
    Int J Clin Lab Res; 1993; 23(4):186-91. PubMed ID: 7510148
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer.
    Ouspenskaia T; Law T; Clauser KR; Klaeger S; Sarkizova S; Aguet F; Li B; Christian E; Knisbacher BA; Le PM; Hartigan CR; Keshishian H; Apffel A; Oliveira G; Zhang W; Chen S; Chow YT; Ji Z; Jungreis I; Shukla SA; Justesen S; Bachireddy P; Kellis M; Getz G; Hacohen N; Keskin DB; Carr SA; Wu CJ; Regev A
    Nat Biotechnol; 2022 Feb; 40(2):209-217. PubMed ID: 34663921
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Defined antigens recognized by T lymphocytes on human tumors.
    Coulie PG; Van Pel A
    Curr Opin Oncol; 1993 Nov; 5(6):1043-8. PubMed ID: 8305537
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Combined assessment of MHC binding and antigen abundance improves T cell epitope predictions.
    Koşaloğlu-Yalçın Z; Lee J; Greenbaum J; Schoenberger SP; Miller A; Kim YJ; Sette A; Nielsen M; Peters B
    iScience; 2022 Feb; 25(2):103850. PubMed ID: 35128348
    [TBL] [Abstract][Full Text] [Related]  

  • 65. SeRenDIP-CE: sequence-based interface prediction for conformational epitopes.
    Hou Q; Stringer B; Waury K; Capel H; Haydarlou R; Xue F; Abeln S; Heringa J; Feenstra KA
    Bioinformatics; 2021 Oct; 37(20):3421-3427. PubMed ID: 33974039
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cancer and depression: cancer presenting with depressive illness: an autoimmune disease?
    Brown JH; Paraskevas F
    Br J Psychiatry; 1982 Sep; 141():227-32. PubMed ID: 6182940
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Treatment of cancer by alteration of a cancer specific surface membrane epitope.
    Field EJ
    Med Hypotheses; 1986 Mar; 19(3):257-9. PubMed ID: 2421141
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Systematic identification of cancer-specific MHC-binding peptides with RAVEN.
    Baldauf MC; Gerke JS; Kirschner A; Blaeschke F; Effenberger M; Schober K; Rubio RA; Kanaseki T; Kiran MM; Dallmayer M; Musa J; Akpolat N; Akatli AN; Rosman FC; Özen Ö; Sugita S; Hasegawa T; Sugimura H; Baumhoer D; Knott MML; Sannino G; Marchetto A; Li J; Busch DH; Feuchtinger T; Ohmura S; Orth MF; Thiel U; Kirchner T; Grünewald TGP
    Oncoimmunology; 2018; 7(9):e1481558. PubMed ID: 30228952
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immunology and human cancer.
    Bray AE
    Aust N Z J Med; 1978 Jun; 8(3):344. PubMed ID: 81048
    [No Abstract]   [Full Text] [Related]  

  • 70. Cross-reactivity between cancer and microbial antigens.
    Zitvogel L; Kroemer G
    Oncoimmunology; 2021 Jan; 10(1):1877416. PubMed ID: 33537178
    [No Abstract]   [Full Text] [Related]  

  • 71. Ionic immune suppression within the tumour microenvironment limits T cell effector function.
    Eil R; Vodnala SK; Clever D; Klebanoff CA; Sukumar M; Pan JH; Palmer DC; Gros A; Yamamoto TN; Patel SJ; Guittard GC; Yu Z; Carbonaro V; Okkenhaug K; Schrump DS; Linehan WM; Roychoudhuri R; Restifo NP
    Nature; 2016 Sep; 537(7621):539-543. PubMed ID: 27626381
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Harnessing Bioinformatics for Designing a Novel Multiepitope Peptide Vaccine Against Breast Cancer.
    Mahmoodi S; Nezafat N; Barzegar A; Negahdaripour M; Nikanfar AR; Zarghami N; Ghasemi Y
    Curr Pharm Biotechnol; 2016; 17(12):1100-1114. PubMed ID: 27633889
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Targeting CD73 in the tumor microenvironment with MEDI9447.
    Hay CM; Sult E; Huang Q; Mulgrew K; Fuhrmann SR; McGlinchey KA; Hammond SA; Rothstein R; Rios-Doria J; Poon E; Holoweckyj N; Durham NM; Leow CC; Diedrich G; Damschroder M; Herbst R; Hollingsworth RE; Sachsenmeier KF
    Oncoimmunology; 2016 Aug; 5(8):e1208875. PubMed ID: 27622077
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Recent advances in T-cell engineering for use in immunotherapy.
    Sharma P; Kranz DM
    F1000Res; 2016; 5():. PubMed ID: 27703664
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Agonistic CD40 mAb-Driven IL12 Reverses Resistance to Anti-PD1 in a T-cell-Rich Tumor.
    Ngiow SF; Young A; Blake SJ; Hill GR; Yagita H; Teng MW; Korman AJ; Smyth MJ
    Cancer Res; 2016 Nov; 76(21):6266-6277. PubMed ID: 27634762
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Deep Mutational Scans as a Guide to Engineering High Affinity T Cell Receptor Interactions with Peptide-bound Major Histocompatibility Complex.
    Harris DT; Wang N; Riley TP; Anderson SD; Singh NK; Procko E; Baker BM; Kranz DM
    J Biol Chem; 2016 Nov; 291(47):24566-24578. PubMed ID: 27681597
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Chimeric Antigen Receptor T Cells and Hematopoietic Cell Transplantation: How Not to Put the CART Before the Horse.
    Kenderian SS; Porter DL; Gill S
    Biol Blood Marrow Transplant; 2017 Feb; 23(2):235-246. PubMed ID: 27638367
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Adoptive Transfer of Tumor-Specific Th2 Cells Eradicates Tumors by Triggering an In Situ Inflammatory Immune Response.
    Lorvik KB; Hammarström C; Fauskanger M; Haabeth OA; Zangani M; Haraldsen G; Bogen B; Corthay A
    Cancer Res; 2016 Dec; 76(23):6864-6876. PubMed ID: 27634753
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Expitope 2.0: a tool to assess immunotherapeutic antigens for their potential cross-reactivity against naturally expressed proteins in human tissues.
    Jaravine V; Mösch A; Raffegerst S; Schendel DJ; Frishman D
    BMC Cancer; 2017 Dec; 17(1):892. PubMed ID: 29282079
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Virotherapy: cancer gene therapy at last?
    Bilsland AE; Spiliopoulou P; Evans TR
    F1000Res; 2016; 5():. PubMed ID: 27635234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.